Hryz Bio Tech
PrivateLast Round
Series C
Extension
Jan 9, 2024
Total Funding Raised
$42.5M
Company Overview
Hryz Bio Tech is a biotechnology company that develops immune cell therapy technologies for solid tumors, with product pipelines including MASCT, TCR-T, and TCR Dual Antibody.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hryz Bio Tech Comparables
Compare Hryz Bio Tech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TCRCure Biopharma | 86% | |
| Lion TCR | 86% | |
| Zhejiang Carbiogene Therapeutics Co. Ltd. | 81% |
Hryz Bio Tech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jan 9, 2024 | ||||
| Series C Extension | Aug 31, 2023 | ||||
| Series C | May 16, 2023 | ||||
| Series B Extension | Dec 6, 2022 | ||||
| Series B | Dec 28, 2020 | ||||
Series A Extension | Sep 2, 2020 |
Hryz Bio Tech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Hengtai Huasheng Asset Management | Series A Extension |
| CCIC Capital | Series B Extension, Series A Extension |
| Sincere Capital | Series B |
| Zicheng Investment | Series A Extension |
| China Science & Merchants Investment Management Group | Series B Extension |
| HongShan Capital Group (HSG) | Series B Extension |
Hryz Bio Tech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hryz Bio Tech's valuation, stock price, and market status.
Is Hryz Bio Tech a public or private company?
Hryz Bio Tech is a private company.
What is the current stock price of Hryz Bio Tech?
Hryz Bio Tech is a private company with no public stock price. No recent secondary market data is available.
How much is Hryz Bio Tech worth (valuation)?
Valuation information for Hryz Bio Tech is not publicly available.
Can I buy Hryz Bio Tech stock?
Hryz Bio Tech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hryz Bio Tech's last funding round?
Hryz Bio Tech's most recent funding round was Series C Extension on January 9, 2024.
Who are the main investors in Hryz Bio Tech?
Key investors in Hryz Bio Tech include Shenzhen Hengtai Huasheng Asset Management, CCIC Capital, Sincere Capital, Zicheng Investment, China Science & Merchants Investment Management Group.
Will Hryz Bio Tech IPO soon?
No public IPO plans have been announced for Hryz Bio Tech.
How can I track Hryz Bio Tech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hryz Bio Tech's secondary market activity and sign up for updates.